Study #2021-1015
A randomized, prospective study of a behaviorally-based tailored disease management intervention vs control in patients with risk factors for liver disease
MD Anderson Study Status
Enrolling
Treatment Agent
Description
To determine the effectiveness of a behaviorally-based tailored disease management intervention in patients with fibrosis or steatosis and risk factors for cirrhosis.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Liver Diseases;Fibrosis, Liver;Cirrhosis, Liver
Study phase:
Not applicable
Physician name:
Karen Basen-Engquist
Department:
Behavioral Science
For general questions about clinical trials:
1-844-285-5619
Help #EndCancer
Give Now
Your gift will help make a tremendous difference.
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.